Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Free PDFs:
Hepatology 2014 (5th Edition, 612 pages)
Short Guide to Hepatitis C (2014 Edition, 206 pages)

Free Abstracts

  Hepatitis

  Free Subscription


28.07.2014

1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
2 Gastroenterology
11 Hepatology
3 J Hepatol
5 J Med Virol
8 J Viral Hepat
4 JAMA
1 MMWR Morb Mortal Wkly Rep
2 Pediatr Infect Dis J
4 PLoS One
1 Proc Natl Acad Sci U S A
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. CZAJA AJ
    Targeting Apoptosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2014.
    PubMed     Text format     Related articles    Abstract available


    Eur J Gastroenterol Hepatol

  2. ASSAL A, Mackie D, Cooper CL
    Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available

  3. BAKER D, Alavi M, Erratt A, Hill S, et al
    Delivery of treatment for hepatitis C virus infection in the primary care setting.
    Eur J Gastroenterol Hepatol. 2014.
    PubMed     Text format     Related articles    Abstract available


    Gastroenterol Hepatol

  4. FERNANDEZ FERNANDEZ N, Joao Matias D, Pisabarros Blanco C, Rodriguez Martin L, et al
    [Hepatitis induced by glatiramer acetate.]
    Gastroenterol Hepatol. 2014 Jul 17. pii: S0210-5705(14)00173.
    PubMed     Text format     Related articles   


    Gastroenterology

  5. BERGER C, Romero-Brey I, Radujkovic D, Terreux R, et al
    Daclatasvir-like Inhibitors of NS5A Block Early Biogenesis of HCV-induced Membranous Replication Factories, Independent of RNA Replication.
    Gastroenterology. 2014 Jul 18. pii: S0016-5085(14)00915.
    PubMed     Text format     Related articles    Abstract available

  6. ABDEL-HAKEEM MS, Bedard N, Murphy D, Bruneau J, et al
    Signatures of Protective Memory Immune Responses During HCV Reinfection.
    Gastroenterology. 2014 Jul 16. pii: S0016-5085(14)00901.
    PubMed     Text format     Related articles    Abstract available


    Hepatology

  7. YAMASAKI K, Tateyama M, Abiru S, Komori A, et al
    Elevated serum levels of WFA -M2BP predict the development of hepatocellular carcinoma in hepatitis C patients.
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27305.
    PubMed     Text format     Related articles    Abstract available

  8. GRANT CR, Liberal R, Ma Y, Robson SC, et al
    Reply to phenotypic alterations of regulatory T cells in autoimmune hepatitis: Causal or associated with treatment and remission?
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27309.
    PubMed     Text format     Related articles   

  9. B J, T A, M K, A O, et al
    Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada.
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27310.
    PubMed     Text format     Related articles    Abstract available

  10. CORTESI PA, Scalone L, Mantovani LG
    Cost-Effectiveness Analysis of New Drugs for Chronic Hepatitis C: The Importance of Updating Utility Values.
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27316.
    PubMed     Text format     Related articles   

  11. TSOCHATZIS EA, Crossan C, Longworth L, Gurusamy K, et al
    Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.
    Hepatology. 2014 Jul 4. doi: 10.1002/hep.27296.
    PubMed     Text format     Related articles    Abstract available

  12. CARLSEN TH, Pedersen J, Prentoe JC, Giang E, et al
    Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.
    Hepatology. 2014 Jul 8. doi: 10.1002/hep.27298.
    PubMed     Text format     Related articles    Abstract available

  13. SEBODE M, Peiseler M, Weiler-Normann C, Schramm C, et al
    Phenotypic alterations of regulatory T cells in autoimmune hepatitis: causal or associated with treatment and remission?
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27301.
    PubMed     Text format     Related articles   

  14. KAZANKOV K, M Ller HJ, Bibby BM, Vilstrup H, et al
    Soluble CD163 correlates with the fibrosis models APRI and FIB-4 and independently predicts liver fibrosis in chronic HBV and HCV infection.
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27302.
    PubMed     Text format     Related articles   

  15. FELMLEE DJ, Schuster C, Baumert TF
    A new tool for the study of hepatitis C virus genotype 3 and its associated liver disease biology.
    Hepatology. 2014 Jul 21. doi: 10.1002/hep.27326.
    PubMed     Text format     Related articles   

  16. REHERMANN B, Bertoletti A
    Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.
    Hepatology. 2014 Jul 21. doi: 10.1002/hep.27323.
    PubMed     Text format     Related articles    Abstract available

  17. KUNIHOLM MH, Hanna DB, Landay AL, Kaplan RC, et al
    sCD163 is associated with non-invasive measures of liver fibrosis in HCV- and HCV/HIV-infected women.
    Hepatology. 2014 Jul 12. doi: 10.1002/hep.27303.
    PubMed     Text format     Related articles   


    J Hepatol

  18. DEBING Y, Neyts J
    mTOR-inhibitors may aggravate chronic hepatitis E.
    J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00515.
    PubMed     Text format     Related articles   

  19. MARCELLIN P, Buti M, Krastev Z, de Man RA, et al
    Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.
    J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00518.
    PubMed     Text format     Related articles    Abstract available

  20. BRONOWICKI JP, Ratziu V, Gadano A, Thuluvath PJ, et al
    Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C.
    J Hepatol. 2014 Jul 16. pii: S0168-8278(14)00480.
    PubMed     Text format     Related articles    Abstract available


    J Med Virol

  21. HAJARIZADEH B, Grebely J, Applegate T, Matthews GV, et al
    Dynamics of HCV RNA levels during acute hepatitis C virus infection.
    J Med Virol. 2014 Jul 8. doi: 10.1002/jmv.24010.
    PubMed     Text format     Related articles    Abstract available

  22. LIVRAMENTO AD, Schultz J, Batista KZ, Treitinger A, et al
    Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13-18 years after primary vaccination.
    J Med Virol. 2014 Jul 5. doi: 10.1002/jmv.24012.
    PubMed     Text format     Related articles    Abstract available

  23. ZHANG F, Qi Y, Harrison TJ, Luo B, et al
    Hepatitis E genotype 4 virus from feces of monkeys infected experimentally can be cultured in PLC/PRF/5 cells and upregulate host interferon-inducible genes.
    J Med Virol. 2014 Jul 11. doi: 10.1002/jmv.24014.
    PubMed     Text format     Related articles    Abstract available

  24. DE CARVALHO IM, Alves R, de Souza PA, da Silva EF, et al
    Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: Novel insights about targeted genotyping approaches.
    J Med Virol. 2014 Jul 11. doi: 10.1002/jmv.24015.
    PubMed     Text format     Related articles    Abstract available

  25. AHERFI S, Solas C, Motte A, Moreau J, et al
    Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
    J Med Virol. 2014 Jul 23. doi: 10.1002/jmv.24016.
    PubMed     Text format     Related articles    Abstract available


    J Viral Hepat

  26. ZHANG JJ, Fan YC, Zhang ZH, Han J, et al
    Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute-on-chronic hepatitis B liver failure.
    J Viral Hepat. 2014 Jul 21. doi: 10.1111/jvh.12286.
    PubMed     Text format     Related articles    Abstract available

  27. PAPATHEODORIDIS GV, Manolakopoulos S, Touloumi G, Nikolopoulou G, et al
    Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.
    J Viral Hepat. 2014 Jul 15. doi: 10.1111/jvh.12283.
    PubMed     Text format     Related articles    Abstract available

  28. MELHEM NM, Talhouk R, Rachidi H, Ramia S, et al
    Hepatitis A virus in the Middle East and North Africa region: a new challenge.
    J Viral Hepat. 2014 Jul 15. doi: 10.1111/jvh.12282.
    PubMed     Text format     Related articles    Abstract available

  29. NOVEMBRINO C, Aghemo A, Ferraris Fusarini C, Maiavacca R, et al
    Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
    J Viral Hepat. 2014 Jul 14. doi: 10.1111/jvh.12281.
    PubMed     Text format     Related articles    Abstract available

  30. CORTESI PA, Ciaccio A, Rota M, Lim JK, et al
    Management of treatment-naive chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.
    J Viral Hepat. 2014 Jul 10. doi: 10.1111/jvh.12278.
    PubMed     Text format     Related articles    Abstract available

  31. FABRIZI F, Dixit V, Messa P, Martin P, et al
    Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.
    J Viral Hepat. 2014 Jul 16. doi: 10.1111/jvh.12276.
    PubMed     Text format     Related articles    Abstract available

  32. BOESECKE C, van Assen S, Stellbrink HJ, Baumgarten A, et al
    Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection.
    J Viral Hepat. 2014 Jul 9. doi: 10.1111/jvh.12272.
    PubMed     Text format     Related articles    Abstract available

  33. GREGORY A, Vedio A, Stone B, Green S, et al
    Targeted testing in primary care demonstrates high prevalence of hepatitis B infection within the Slovak-Roma population in Sheffield, UK.
    J Viral Hepat. 2014 Jul 24. doi: 10.1111/jvh.12287.
    PubMed     Text format     Related articles   


    JAMA

  34. KONERMAN MA, Lok AS
    Diagnostic Challenges of Hepatitis C.
    JAMA. 2014;311:2536-2537.
    PubMed     Text format     Related articles   

  35. BRENNAN T, Shrank W
    New Expensive Treatments for Hepatitis C Infection.
    JAMA. 2014 Jul 20. doi: 10.1001/jama.2014.8897.
    PubMed     Text format     Related articles   

  36. SULKOWSKI MS, Naggie S, Lalezari J, Fessel WJ, et al
    Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.
    JAMA. 2014;312:353-61.
    PubMed     Text format     Related articles    Abstract available

  37. SAAG MS
    Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.
    JAMA. 2014;312:347-8.
    PubMed     Text format     Related articles   


    MMWR Morb Mortal Wkly Rep

  38. APATA IW, Averhoff F, Pitman J, Bjork A, et al
    Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection - sub-saharan Africa, 2000-2011.
    MMWR Morb Mortal Wkly Rep. 2014;63:613-9.
    PubMed     Text format     Related articles    Abstract available


    Pediatr Infect Dis J

  39. THOLLOT F, Scheifele D, Pankow-Culot H, Cheuvart B, et al
    A Randomized Study to Evaluate the Immunogenicity and Safety of a Heptavalent Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus influenzae b, and Meningococcal Serogroup C Combination Vaccine Administered to Infants at 2, 4, and
    Pediatr Infect Dis J. 2014.
    PubMed     Text format     Related articles    Abstract available

  40. HIEU NT, Sarnecki M, Tolboom J
    The Safety and Immunogenicity of Two Hepatitis B Vaccine Formulations (Thiomersal-Free and Thiomersal-Containing) in Healthy Vietnamese Infants: A Phase III, Prospective, Single-Blinded, Randomized, Controlled Trial.
    Pediatr Infect Dis J. 2014.
    PubMed     Text format     Related articles    Abstract available


    PLoS One

  41. CACHAY ER, Hill L, Wyles D, Colwell B, et al
    The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care.
    PLoS One. 2014;9:e102883.
    PubMed     Text format     Related articles    Abstract available

  42. TZENG HT, Tsai HF, Chyuan IT, Liao HJ, et al
    Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model.
    PLoS One. 2014;9:e103008.
    PubMed     Text format     Related articles    Abstract available

  43. SUN P, Dong X, Cheng X, Hu Q, et al
    Nucleot(s)ide Analogues for Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Treatment: A Systematic Review and Meta-Analysis.
    PLoS One. 2014;9:e102761.
    PubMed     Text format     Related articles    Abstract available

  44. LIMA LR, Almeida AJ, Tourinho Rdos S, Hasselmann B, et al
    Evidence of Hepatitis A Virus Person-to-Person Transmission in Household Outbreaks.
    PLoS One. 2014;9:e102925.
    PubMed     Text format     Related articles    Abstract available


    Proc Natl Acad Sci U S A

  45. WANG JC, Nickens DG, Lentz TB, Loeb DD, et al
    Encapsidated hepatitis B virus reverse transcriptase is poised on an ordered RNA lattice.
    Proc Natl Acad Sci U S A. 2014 Jul 17. pii: 201321424.
    PubMed     Text format     Related articles    Abstract available


    Vaccine

  46. GAGGAR A, Coeshott C, Apelian D, Rodell T, et al
    Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study.
    Vaccine. 2014 Jul 18. pii: S0264-410X(14)00953.
    PubMed     Text format     Related articles    Abstract available


    Virology

  47. AN Y, Wu T, Wang M, Lu L, et al
    Conservation in China of a novel group of HCV variants dating to six centuries ago.
    Virology. 2014;464-465C:21-25.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: